# FDA EIR - REATA PHARMACEUTICALS - July 13, 2021

Source: https://www.globalkeysolutions.net/records/eir/reata-pharmaceuticals/695127c1-d336-4d90-9342-0e7a8f2cd5f6

> FDA EIR for REATA PHARMACEUTICALS on July 13, 2021. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: REATA PHARMACEUTICALS
- Inspection Date: 2021-07-13
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Officers

- [company_representative](https://www.globalkeysolutions.net/people/author-gibson/058384f3-3fc3-4e9e-a858-312765cc530c)
- [company_representative](https://www.globalkeysolutions.net/people/tracy-herson/1f4c7f74-d27e-4b64-8267-64b934c0031c)
- [recipient](https://www.globalkeysolutions.net/people/james-w-huff/34aa9ac0-04eb-42d7-bdee-0a120e9c7a7c)
- [company_representative](https://www.globalkeysolutions.net/people/vincent-badalamenti/38331060-f5aa-43ed-b9d9-42d11ea313a0)
- [company_representative](https://www.globalkeysolutions.net/people/steve-kirby/4f6f5d2a-c3d4-4263-ade5-e39bc1f98bb8)

Company: https://www.globalkeysolutions.net/companies/reata-pharmaceuticals/90089a9c-06f6-4450-aefa-9e6489b27330

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c